BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28461575)

  • 1. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
    Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E; Wu Z; Shon JC; Liu KH
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
    Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
    Lee E; Kim JH; Shon JC; Wu Z; Kim HJ; Gim M; Lee T; Liu KH
    Drug Metab Pharmacokinet; 2018 Jun; 33(3):159-163. PubMed ID: 29759885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.
    Zhao T; Chen Y; Wang D; Wang L; Dong P; Zhao S; Wang C; Meng Q; Sun H; Liu K; Wu J
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):121-129. PubMed ID: 33411110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of decursin to inhibit the human cytochrome P450 2J2 isoform.
    Lee B; Wu Z; Sung SH; Lee T; Song KS; Lee MY; Liu KH
    Food Chem Toxicol; 2014 Aug; 70():94-9. PubMed ID: 24788058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9.
    Tracy TS; Marra C; Wrighton SA; Gonzalez FJ; Korzekwa KR
    Biochem Pharmacol; 1996 Oct; 52(8):1305-9. PubMed ID: 8937439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
    Park SH; Lee J; Shon JC; Phuc NM; Jee JG; Liu KH
    Phytomedicine; 2018 Mar; 42():199-206. PubMed ID: 29655687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylshikonin is a novel non-selective cytochrome P450 inhibitor.
    Shon JC; Phuc NM; Kim WC; Heo JK; Wu Z; Lee H; Liu KH
    Biopharm Drug Dispos; 2017 Dec; 38(9):553-556. PubMed ID: 28866862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
    Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Xu S; Zhang F; Chen D; Su K; Zhang L; Jiang R
    Pharm Biol; 2020 Dec; 58(1):308-313. PubMed ID: 32285742
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
    Wei J; Zhang H; Zhao Q
    Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
    Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes.
    Dong G; Zhou Y; Song X
    Pharm Biol; 2018 Dec; 56(1):620-625. PubMed ID: 31070542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
    Ikemura N; Yamaori S; Kobayashi C; Kamijo S; Murayama N; Yamazaki H; Ohmori S
    Chem Biol Interact; 2019 Jun; 306():1-9. PubMed ID: 30965050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.
    Wang L; Zhang D; Raghavan N; Yao M; Ma L; Frost CE; Maxwell BD; Chen SY; He K; Goosen TC; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2010 Mar; 38(3):448-58. PubMed ID: 19940026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450.
    Bojić M; Sedgeman CA; Nagy LD; Guengerich FP
    Eur J Pharm Sci; 2015 Jun; 73():49-56. PubMed ID: 25840124
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Li J; Wen H; Gao Z
    Xenobiotica; 2020 Feb; 50(2):231-236. PubMed ID: 31020909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.